AE Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.3M Buy
323,757
+79,618
+33% +$6.13M 0.13% 177
2025
Q4
$19.4M Sell
244,139
-13,065
-5% -$1.03M 0.11% 192
2025
Q3
$19.4M Buy
257,204
+14,983
+6% +$1.03M 0.12% 179
2025
Q2
$16.7M Buy
242,221
+207,984
+607% +$13.6M 0.12% 183
2025
Q1
$2.32M Sell
34,237
-9,737
-22% -$583K 0.02% 494
2024
Q4
$1.97M Buy
43,974
+4,707
+12% +$264K 0.02% 525
2024
Q3
$2.47M Sell
39,267
-16,849
-30% -$983K 0.02% 474
2024
Q2
$3.31M Buy
56,116
+6,151
+12% +$385K 0.03% 416
2024
Q1
$3.99M Sell
49,965
-189,512
-79% -$14.5M 0.05% 346
2023
Q4
$17.5M Sell
239,477
-123,209
-34% -$8.77M 0.09% 265
2023
Q3
$25.3M Sell
362,686
-9,810
-3% -$695K 0.15% 154
2023
Q2
$25.8M Buy
372,496
+98,457
+36% +$7.01M 0.15% 149
2023
Q1
$20.4M Buy
274,039
+20,819
+8% +$1.75M 0.13% 181
2022
Q4
$23.6M Sell
253,220
-13,070
-5% -$1.26M 0.17% 145
2022
Q3
$25.4M Buy
266,290
+31,606
+13% +$3.13M 0.2% 111
2022
Q2
$21.7M Buy
234,684
+15,592
+7% +$1.52M 0.17% 141
2022
Q1
$22.2M Sell
219,092
-3,331
-1% -$350K 0.15% 148
2021
Q4
$22.9M Buy
222,423
+27,829
+14% +$2.57M 0.16% 130
2021
Q3
$16.5M Buy
194,594
+48,920
+34% +$4.1M 0.14% 165
2021
Q2
$12.2M Buy
145,674
+22,451
+18% +$1.84M 0.11% 192
2021
Q1
$9.27M Buy
123,223
+24,095
+24% +$1.76M 0.09% 218
2020
Q4
$6.77M Buy
99,128
+6,448
+7% +$419K 0.08% 234
2020
Q3
$5.41M Buy
92,680
+4,881
+6% +$304K 0.08% 222
2020
Q2
$5.7M Buy
87,799
+30,330
+53% +$1.91M 0.09% 205
2020
Q1
$3.41M Buy
57,469
+24,629
+75% +$1.64M 0.08% 221
2019
Q4
$2.44M Buy
32,840
+12,449
+61% +$874K 0.05% 300
2019
Q3
$1.29M Sell
20,391
-1,458
-7% -$86.4K 0.04% 379
2019
Q2
$1.19M Buy
21,849
+9,186
+73% +$495K 0.04% 356
2019
Q1
$683K Buy
12,663
+6,913
+120% +$427K 0.05% 282
2018
Q4
$377K Buy
5,750
+313
+6% +$23.4K 0.06% 298
2018
Q3
$428K Buy
5,437
+1,620
+42% +$116K 0.02% 358
2018
Q2
$246K Sell
3,817
-789
-17% -$52K 0.02% 377
2018
Q1
$287K Buy
4,606
+1,802
+64% +$129K 0.02% 335
2017
Q4
$203K Sell
2,804
-7,270
-72% -$529K 0.02% 394
2017
Q3
$819K Sell
10,074
-611
-6% -$48.3K 0.08% 181
2017
Q2
$860K Buy
10,685
+7,300
+216% +$576K 0.1% 167
2017
Q1
$266K Buy
+3,385
New +$270K 0.05% 222

Other funds holding CVS

AE Wealth Management's CVS Position: Q1 2026 in Review

AE Wealth Management increased its CVS Health (CVS) stake by 33% in Q1 2026, buying an estimated $6.13M and bringing the position to 323,757 shares worth $23.3M. The position accounts for 0.13% of the portfolio, ranked #177.

AE Wealth Management first reported a position in CVS in Q1 2017 and has held it in 37 quarters since. The position peaked at $25.8M in Q2 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • AE Wealth Management held 323,757 shares of CVS Health worth $23.3M as of Q1 2026.
  • AE Wealth Management bought 79,618 CVS Health shares in Q1 2026, an estimated $6.13M.
  • CVS Health made up 0.13% of AE Wealth Management's portfolio in Q1 2026, its #177 holding.
  • AE Wealth Management first reported a position in CVS Health in Q1 2017 and has held it in 37 quarters since.
  • AE Wealth Management's CVS Health position peaked at $25.8M in Q2 2023.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.